LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Lantheus
LNTH
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Constellation Brands
STZ
US Stock MarketDetailed Quotes
ALT Altimmune
- 5.990
- -0.660-9.92%
Close Mar 3 16:00 ET
- 6.030
- +0.040+0.67%
Post 20:01 ET
461.31MMarket Cap-4.47P/E (TTM)
6.710High5.930Low2.65MVolume6.710Open6.650Pre Close16.41MTurnover3.47%Turnover RatioLossP/E (Static)77.01MShares11.50052wk High3.73P/B457.31MFloat Cap5.27552wk Low--Dividend TTM76.35MShs Float978.000Historical High--Div YieldTTM11.73%Amplitude-1731.000Historical Low6.201Avg Price1Lot Size
Altimmune Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.33%-79.85M | -10.48%-18.27M | -32.37%-27.12M | 6.58%-18.11M | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M |
| Net income from continuing operations | -7.48%-95.06M | 26.74%-23.18M | -10.52%-22.85M | -53.42%-24.64M | -21.52%-24.39M | -4.41%-88.45M | -46.08%-31.64M | 12.10%-20.67M | 20.12%-16.06M | -3.31%-20.07M |
| Operating gains losses | 68.83%-48K | -485.00%-117K | -500.00%-12K | 164.04%73K | 144.44%8K | -552.94%-154K | -109.22%-20K | 95.92%-2K | -375.00%-114K | 83.64%-18K |
| Depreciation and amortization | -50.10%238K | -71.05%33K | -68.38%37K | -49.59%61K | -14.40%107K | -3.25%477K | -75.32%114K | 182.98%117K | 128.30%121K | 5.04%125K |
| Change In working capital | 154.12%4.48M | 200.12%2.46M | -224.39%-6.4M | 157.50%3.16M | 421.60%5.26M | -158.64%-8.27M | -66.91%821K | -130.21%-1.97M | -916.48%-5.49M | -128.96%-1.63M |
| -Change in receivables | 175.09%1.74M | 168.83%223K | 59.71%-328K | -25.87%-433K | 373.98%2.27M | -170.10%-2.31M | -117.88%-324K | -146.70%-814K | -1,395.65%-344K | -254.70%-830K |
| -Change in prepaid assets | 450.41%4.71M | 13.61%793K | 112.72%228K | 80.75%-354K | 154.63%4.05M | -150.75%-1.35M | 225.99%698K | -829.02%-1.79M | -623.93%-1.84M | -47.83%1.59M |
| -Change in payables and accrued expense | 57.31%-1.97M | 223.94%1.45M | -1,091.65%-6.3M | 219.27%3.94M | 55.50%-1.07M | -156.56%-4.62M | -63.45%447K | -87.24%635K | -280.88%-3.31M | -184.56%-2.39M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.33%-79.85M | -10.48%-18.27M | -32.37%-27.12M | 6.58%-18.11M | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -306.71%-28.39M | 271.28%13.63M | -72.76%1.2M | -192.70%-3.7M | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | 62.70%-47K | --0 | --0 | 121.05%4K | -466.67%-51K |
| Net investment purchase and sale | -306.01%-28.39M | 271.28%13.63M | -72.76%1.2M | -192.79%-3.7M | -395.97%-39.52M | 118.81%13.78M | -881.06%-7.96M | 117.37%4.4M | 108.14%3.98M | --13.35M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -306.71%-28.39M | 271.28%13.63M | -72.76%1.2M | -192.70%-3.7M | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -88.34%10.04M | -86.14%10.09M | -54.76%266K | -100.35%-46K | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K |
| Net common stock issuance | -88.46%9.99M | -86.63%9.69M | -77.80%131K | --0 | 25.19%169K | 53.69%86.6M | --72.52M | -98.15%590K | -45.14%13.35M | 19.47%135K |
| Proceeds from stock option exercised by employees | 174.39%900K | 47.19%393K | --139K | --198K | 178.69%170K | -65.47%328K | 225.61%267K | --0 | --0 | -98.09%61K |
| Net other financing activities | -3.16%-850K | 94.59%-2K | -100.00%-4K | 14.98%-244K | -20.48%-600K | -59.69%-824K | 70.40%-37K | 98.10%-2K | -71.86%-287K | -318.49%-498K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -88.34%10.04M | -86.14%10.09M | -54.76%266K | -100.35%-46K | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K |
| Net cash flow | ||||||||||
| Beginning cash position | 21.62%135.16M | -63.73%31.52M | -44.17%57.17M | -24.55%79.02M | 21.62%135.16M | -41.61%111.13M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M | -41.61%111.13M |
| Current changes in cash | -508.67%-98.19M | -88.70%5.45M | -65.54%-25.65M | -837.37%-21.85M | -776.21%-56.14M | 130.34%24.03M | 394.86%48.26M | -84.64%-15.5M | 94.71%-2.33M | 38.12%-6.41M |
| End cash Position | -72.65%36.97M | -72.65%36.97M | -63.73%31.52M | -44.17%57.17M | -24.55%79.02M | 21.62%135.16M | 21.62%135.16M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M |
| Free cash flow | -5.26%-79.85M | -10.48%-18.27M | -32.37%-27.12M | 6.56%-18.11M | 15.94%-16.36M | -20.96%-75.86M | 4.68%-16.53M | -35.59%-20.49M | -15.88%-19.38M | -43.76%-19.46M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
